Search

Search Constraints

You searched for: Author/Creator Vitrano, Angela

Search Results

1. A complication risk score to evaluate clinical severity of thalassaemia syndromes. (20th November 2020)

2. Deferiprone versus deferoxamine in thalassemia intermedia: Results from a 5‐year long‐term Italian multicenter randomized clinical trial. Issue 7 (3rd May 2015)

3. Evaluation of the efficacy and safety of deferiprone compared with deferasirox in paediatric patients with transfusion-dependent haemoglobinopathies (DEEP-2): a multicentre, randomised, open-label, non-inferiority, phase 3 trial. Issue 6 (June 2020)

5. Longitudinal changes in LIC and other parameters in patients receiving different chelation regimens: Data from LICNET. (7th December 2017)

6. Long‐term sequential deferiprone and deferasirox therapy in transfusion‐dependent thalassaemia patients: a prospective clinical trial. (25th July 2019)

7. Primary HBB gene mutation severity and long‐term outcomes in a global cohort of β‐thalassaemia. (25th October 2021)

8. Real‐life experience with liver iron concentration R2 MRI measurement in patients with hemoglobinopathies: baseline data from LICNET. (23rd February 2016)

9. Risk of mortality from anemia and iron overload in nontransfusion‐dependent β‐thalassemia. Issue 2 (10th December 2021)

10. The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major‐intermedia dichotomy?. (17th October 2016)